Table 10.
Known genes that were differentially expressed in X-irradiated mouse brain regions relative to a matched, unirradiated control group using a non-FDR-adjusted statistical approach (p ≤ 0.05), with a minimum fold change of 1.5.
| Brain region | Probe ID | Accession No. | Gene symbol | Fold change | Description |
|---|---|---|---|---|---|
| Auditory cortex | ILMN_2971479 | NM_021897 | Trp53inp1 | 1.91 up | transformation related protein 53 inducible nuclear protein 1, transcript variant 1 |
| ILMN_2634083 | NM_007669 | Cdkn1a | 1.86 up | cyclin-dependent kinase inhibitor 1A (P21), transcript variant 1 | |
| ILMN_3081854 | NM_001025245 | Mbp | 1.56 up | myelin basic protein, transcript variant 8 | |
| Amygdala | ILMN_2971479 | NM_021897 | Trp53inp1 | 1.97 up | transformation related protein 53 inducible nuclear protein 1, transcript variant 1 |
| ILMN_2634083 | NM_007669 | Cdkn1a | 1.87 up | cyclin-dependent kinase inhibitor 1A (P21), transcript variant 1 | |
| Caudate | ILMN_2750515 | NM_010234 | Fos | 2.15 down | FBJ osteosarcoma oncogene |
| ILMN_2634083 | NM_007669 | Cdkn1a | 2.03 up | cyclin-dependent kinase inhibitor 1A (P21), transcript variant 1 | |
| ILMN_2800505 | NM_010053 | Dlx1 | 1.99 down | distal-less homeobox 1 | |
| ILMN_2971479 | NM_021897 | Trp53inp1 | 1.84 up | transformation related protein 53 inducible nuclear protein 1, transcript variant 1 | |
| ILMN_2701881 | NM_010444 | Nr4a1 | 1.81 down | nuclear receptor subfamily 4, group A, member 1 | |
| ILMN_2860959 | NM_010054 | Dlx2 | 1.81 down | distal-less homeobox 2 | |
| ILMN_2629112 | NM_139306 | Acer2 | 1.79 up | alkaline ceramidase 2, transcript variant 1 | |
| ILMN_2855315 | NM_015786 | Hist1h1c | 1.60 up | histone cluster 1, H1c | |
| ILMN_2656748 | NM_010145 | Ephx1 | 1.52 up | epoxide hydrolase 1, microsomal | |
| ILMN_2628567 | NM_013750 | Phlda3 | 1.52 up | pleckstrin homology-like domain, family A, member 3 | |
| Cerebellum | ILMN_2634083 | NM_007669 | Cdkn1a | 3.00 up | cyclin-dependent kinase inhibitor 1A (P21), transcript variant 1 |
| ILMN_2971479 | NM_021897 | Trp53inp1 | 2.31 up | transformation related protein 53 inducible nuclear protein 1, transcript variant 1 | |
| ILMN_2923607 | NM_013750 | Phlda3 | 1.78 up | pleckstrin homology-like domain, family A, member 3 | |
| ILMN_1256476 | NM_022032 | Perp | 1.57 up | PERP, TP53 apoptosis effector | |
| ILMN_2629112 | NM_139306 | Acer2 | 1.51 up | alkaline ceramidase 2, transcript variant 1 | |
| Hippocampus | ILMN_2971479 | NM_021897 | Trp53inp1 | 2.34 up | transformation related protein 53 inducible nuclear protein 1, transcript variant 1 |
| ILMN_2634083 | NM_007669 | Cdkn1a | 2.29 up | cyclin-dependent kinase inhibitor 1A (P21), transcript variant 1 | |
| ILMN_1229726 | NM_178887 | Fibcd1 | 1.92 down | fibrinogen C domain containing 1 | |
| ILMN_2750515 | NM_010234 | Fos | 1.71 down | FBJ osteosarcoma oncogene | |
| ILMN_2628567 | NM_013750 | Phlda3 | 1.61 up | pleckstrin homology-like domain, family A, member 3 | |
| ILMN_2701881 | NM_010444 | Nr4a1 | 1.57 down | nuclear receptor subfamily 4, group A, member 1 | |
| Hypothalamus | ILMN_2634083 | NM_007669 | Cdkn1a | 2.75 up | cyclin-dependent kinase inhibitor 1A (P21), transcript variant 1 |
| ILMN_2971479 | NM_021897 | Trp53inp1 | 2.43 up | transformation related protein 53 inducible nuclear protein 1, transcript variant 1 | |
| ILMN_2750515 | NM_010234 | Fos | 1.75 down | FBJ osteosarcoma oncogene | |
| ILMN_2656748 | NM_010145 | Ephx1 | 1.69 up | epoxide hydrolase 1, microsomal | |
| Medial prefrontal cortex | ILMN_2750515 | NM_010234 | Fos | 2.29 down | FBJ osteosarcoma oncogene |
| ILMN_2971479 | NM_021897 | Trp53inp1 | 2.13 up | transformation related protein 53 inducible nuclear protein 1, transcript variant 1 | |
| ILMN_2634083 | NM_007669 | Cdkn1a | 1.67 up | cyclin-dependent kinase inhibitor 1A (P21), transcript variant 1 | |
| ILMN_1235372 | NM_008220 | Hbb-bt | 1.67 down | hemoglobin, beta adult t chain | |
| ILMN_2840082 | NM_027571 | P2ry12 | 1.50 down | purinergic receptor P2Y, G-protein coupled 12 |
FDR: false discovery rate.